Antiviral Treatment Fails to Slow Early-Stage Alzheimer’s

Davangere P. Devanand, MD, professor of psychiatry and neurology and director of geriatric psychiatry, led a study at Columbia University Vagelos College of Physicians and Surgeons that aimed to examine the connection between Alzheimer’s disease and antiviral medication such as valacyclovir. Previous studies have shown that there may be a possible link between treatment for herpes infection and decreased likelihood of developing Alzheimer’s. “Based on those previous studies, there was hope that valacyclovir could have an effect,” said Dr. Devanand. “But no one had conducted a clinical trial to test the idea.” [read more]

Source: CUIMC Newsroom